The Administrative Core is responsible for providing administrative and organizational support for the leadership of the Mayo Clinic Breast Cancer SPORE in order to ensure optimal function of all SPORE components, and communications between the SPORE, Mayo Clinic Cancer Center, Mayo Clinic as a whole, other breast SPOREs, other Mayo SPOREs, SPORE collaborations with non-SPORE funding Instruments, and the National Cancer Institute. An important responsibility ofthe Administrative Core is to support the activities of the Breast SPORE Advocacy Advisory Committee and, in particular, facilitate the integration of the project-specific advocates into the activities of their respective projects. This Core is crucial to the optimal integration of all SPORE activities that are necessary for effective and efficient oversight. The Administrative Core will coordinate the activities of the SPORE Executive Committee, the SPORE Advocacy Advisory Committee, the Mayo Inter-SPORE Advisory Committee, the SPORE Internal Scientific Advisory Committee, the SPORE External Advisory Board, and the Breast SPORE Operations Committee. All ofthe committees have specific functions focusing on maximizing the translational research productivity. This Core will also provide administrative support for the activities of the Developmental Research Program and the Career Development Program. The Administrative Core will assist the SPORE Director in coordinating and facilitating the Research Projects and ensuring the proper functioning ofthe Cores in support of the translational research efforts. This Core will coordinate the monthly SPORE scientific meetings, the monthly Key Personnel meetings, the Breast SPORE involvement in the annual Mayo InterSPORE Retreat, and the participation of Breast SPORE investigators in the Annual Translational Science Meeting in Washington, DC. The Core will provide administrative assistance to the SPORE Director in terms of oversight of all SPORE activities including the research projects, functioning ofthe Biospecimen and Pathology Core and the Biostatistics and Patients Registry Core, the Developmental Research Program, the Career Development Program, and all fiscal matters. The Administrative Core will assist the SPORE Director in preparation of all annual Progress Reports to NCI, the competitive renewal application, and all other reports related to the SPORE award.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA116201-09
Application #
8757105
Study Section
Special Emphasis Panel (ZCA1-RPRB-7)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
9
Fiscal Year
2014
Total Cost
$148,934
Indirect Cost
$40,483
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Tu, Xinyi; Kahila, Mohamed M; Zhou, Qin et al. (2018) ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer. Mol Cancer Ther 17:2462-2472
Athreya, Arjun P; Gaglio, Alan J; Cairns, Junmei et al. (2018) Machine Learning Helps Identify New Drug Mechanisms in Triple-Negative Breast Cancer. IEEE Trans Nanobioscience 17:251-259
Wiese, Elizabeth K; Hitosugi, Taro (2018) Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect. Front Cell Dev Biol 6:79
Frank, Ryan D; Winham, Stacey J; Vierkant, Robert A et al. (2018) Evaluation of 2 breast cancer risk models in a benign breast disease cohort. Cancer 124:3319-3328
Degnim, Amy C; Winham, Stacey J; Frank, Ryan D et al. (2018) Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia. J Clin Oncol 36:1840-1846
Ohmine, Seiga; Salisbury, Jeffrey L; Ingle, James et al. (2018) Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells. Oncol Rep 39:1725-1730
Kourtidis, Antonis; Anastasiadis, Panos Z (2018) Close encounters of the RNAi kind: the silencing life of the adherens junctions. Curr Opin Cell Biol 54:30-36
Leon-Ferre, Roberto A; Polley, Mei-Yin; Liu, Heshan et al. (2018) Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat 167:89-99
Ho, Ming-Fen; Lummertz da Rocha, Edroaldo; Zhang, Cheng et al. (2018) TCL1A, a Novel Transcription Factor and a Coregulator of Nuclear Factor ?B p65: Single Nucleotide Polymorphism and Estrogen Dependence. J Pharmacol Exp Ther 365:700-710
Horne, Hisani N; Oh, Hannah; Sherman, Mark E et al. (2018) E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. Sci Rep 8:6574

Showing the most recent 10 out of 473 publications